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Abstract
Background: Functional tests are widely used to measure performance in patients with chronic musculoskeletal pain.
Our objective was to determine the Minimal Clinically Important Differences (MCID) for the 6-min walk test (6MWT), the
Steep Ramp Test (SRT), the 1-min stair climbing test (1MSCT), the sit-to-stand test (STS), the Jamar dynamometer test
(JAM) and the lumbar Progressive Isoinertial Lifting Evaluation (PILE) in chronic musculoskeletal pain patients.
Methods: A single-center prospective observational study was conducted in a rehabilitation center. Patients with upper-
limb, lower-limb or neck/back lesions were included over a period of 21months. We used the anchor-based method as
a reference method, supplemented by the distribution-based and opinion-based approaches, to determine the MCIDs.
Results: 838 chronic musculoskeletal pain patients were included. The estimation method and thelesion location had a
significant influence on the results. MCIDs were estimated at +75m and +60m for the 6MWT (lower-limb and neck/back
lesions, respectively), +18 steps for the 1MSCT (lower-limb and neck/back lesions) and +6kg for the JAM (upper limb
lesions). The anchor-based method could not provide valid estimations for the three other scales, but distribution and
opinion-based methods provided rough values of MCIDs for the SRT (+39w to +61w), the STS (-5 sec to -7 sec) and the
PILE (+4kg to +7kg).
Conclusion: The above MCID estimations for the 6MWT, 1MSCT and JAM can be used in chronic musculoskeletal pain
patients participating in vocational multidisciplinary rehabilitation programs or in therapeutic trials. The use of specific
anchors might give better estimations of MCIDs for the three other scales in future research.
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Background
The prevalence of chronic (more than 3months) muscu-
loskeletal pain is higher than 20% in industrial countries
[1]. It contributes to physical disability [2] and, according
to Swiss federal statistics [3], costs from $6 to 14 billion a
year in Switzerland (11 to 25% of the Gross Domestic
Product). Evaluations of pain and functional status are
major issues for chronic musculoskeletal pain patients.
Many performance tests are currently being used by clini-
cians, especially in rehabilitation centers. Among these
tests, the 6-min walk test (6MWT) [4], the Steep Ramp
Test (SRT) [5], the 1-Minute Stair Climbing Test
(1MSCT) [6], the Sit-To-Stand test (STS) [7], the Jamar
dynamometer test (JAM) [8] and the lumbar protocol of
the Progressive Isoinertial Lifting Evaluation (PILE) [9] are
widely used in patients with musculoskeletal, neurological,
cardiac or pulmonary disease. These tests are easy to ad-
minister and do not require expensive devices.
In clinical research, small improvements in patient-re-
ported outcomes may be statistically significant, but clin-
ically irrelevant. The concept of “Minimal Clinically
Important Difference” (MCID) was introduced by
Jaesche et al. in 1989 to study the clinical importance of
such improvements [10]. The MCID of a clinical scale is
very useful to know, as it is the smallest change in an
outcome that a patient would identify as important.
MCID values can of course be used by clinicians in daily
clinical practice, but are also helpful for research pur-
poses. For example, the MCID can be used to estimate
the number of subjects required in a therapeutic trial.
MCIDs of the 6MWT have been estimated for patients
with coronary artery disease [11], chronic obstructive
pulmonary disease [12] and Duchenne muscular dys-
trophy [13], but has never been estimated in chronic
musculoskeletal pain patients. Similarly, apart from the
PILE which was evaluated in patients with low back pain
completing a functional restoration program [14], the
MCID of the other tests was not evaluated in chronic
musculoskeletal pain patients.
Three general approaches are currently used to determine
the MCID of a clinical scale [15]: anchor-based methods,
distribution-based methods and opinion methods.
- In the anchor-based method, the change in the out-
come measure is compared with a subjective anchor
variable completed by the patient. For example, patients
are asked to rate their perceived global evolution from
before to after the treatment with a 7-level Global Rating
of Change (GRC) from − 3: “much worse”, to + 3: “much
better” [16]. The binary anchor variable is then com-
pared with the outcome measure using ROC curve tech-
niques [17]. Additionally, the “credibility” of the anchor
is settled if its correlation with the change in the clinical
scale is higher than 0.3–0.4 [18, 19]. Otherwise, the an-
chor should be considered inappropriate for establishing
the MCID. For some authors, this method is the best be-
cause it relies on the patient’s subjective assessment
[19–22]. For this reason, it was considered as the refer-
ence method in the present work.
- In the distribution method, the change in the out-
come score is compared with a measure of variability. For
example, the Standard Error of Measurement (SEM) is
the score’s variation due to unreliability. The distribution
method is useful to evaluate in cases where the anchor
technic is inappropriate or produces lower MCID values.
The MCID should be at least equal to the SEM [23].
- The opinion-based approach consists in gathering opin-
ions of experts (or patients), using an iterative consensus
approach like the Delphi method (see an example in [24]).
Our main objective was to determine MCIDs for the
6MWT, PILE, SRT, 1MSCT, STS and JAM in chronic
musculoskeletal pain patients presenting with upper-limb,
lower-limb and neck/back lesions and undergoing a multi-
disciplinary functional rehabilitation program. A secondary
objective was to compare MCIDs using the opinion-
based methods with those obtained using the reference
Anchor-based and the distribution-based approaches.
Methods
Study design and setting
A single-center prospective study was conducted in a
140-bed rehab center in the French-speaking part of
Switzerland. All rehab inpatients of working age (18–65)
and admitted for chronic musculoskeletal pain between
May 2014 and January 2016 after an acute orthopedic
injury of neck/back, upper limb or lower limb were con-
sidered for inclusion.
Participants
Inclusion criteria were as follows: French-speaking
working-age patients, able to understand and sign the
study informed consent form, able to answer the ques-
tionnaires used in the study, suffering from chronic
musculoskeletal pain (at least 3 months). Patients were
excluded from the study if they met any of the following
criteria: under legal custody (whatever the reason), more
than one of the three defined lesion locations, severe
traumatic brain injury at the time of the accident if any
(Glasgow coma Scale ≤8), spinal cord injury, injury
severity graded ≥3 according to the Abbreviated Injury
Scale (1 = minor, 2 = moderate, 3 = serious, 4 = severe,
5 = critical, 6 = maximal, currently untreatable) [25].
The study was approved by the local ethics committee
(CCVEM 034/12). All participants signed an informed
consent form before enrolment.
Rehabilitation program
During their stay in the rehabilitation clinic, all patients
received four to six therapy sessions a day, 5 days a week
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for 4–5 weeks. Sessions included physiotherapy (individual
sessions), physical reconditioning (class-based strengthen-
ing, balance and stretching), occupational therapy, voca-
tional therapy and cognitive-behavioral therapies.
Functional tests
The following functional tests are part of the systematic
assessment made at intake and discharge in our rehab
center. They all are easy to administer and have good
psychometric properties.
- The 6MWT measures the distance an individual is
able to walk as quickly as possible in a total of six mi-
nutes on a flat surface [4].
- The SRT is an incremental graded exercise test on a
cycloergometer (70–80 rpm), were the load increases by
25 watts every 10 s until the patient’s exhaustion. The test
ends when the pedal frequency falls under 60 rpm [5].
- The 1MSCT: The patient is invited to walk up and
down stairs (one step at a time) for 1 min, the score be-
ing the total number of steps climbed [6].
- The STS: The patient sits in a chair with his back
against the back of the chair, and is asked to stand up
straight as quickly as possible five times, without stop-
ping in between. The score is the time required to
complete the test [7].
- The Jamar Handgrip Dynamometer measures the
maximum isometric grip strength. The dynamometer is
set to the second handle position and the test is per-
formed three times with both hands; the score is the
average of the six measurements in kg [8].
- The lumbar PILE involves lifting weights placed in a
box from the floor to waist height (0-76 cm), four times in
20 s. The weight is increased incrementally by 2.5 kg/5 kg
(women/men), starting with 5 kg/7.5 kg (women/men).
The test is terminated (1) by the subjects themselves
(fatigue, excessive discomfort or inability); (2) by the
examiner if the subject’s heart rate reaches 85% of the
age-determined maximum heart rate; or (3) when the sub-
ject reaches the limit of 55 to 60% of his body weight [9].
Patients with neck/back and lower-limb lesions per-
formed the 6MWT, SRT, 1MSCT and STS, patients with
upper-limb lesions performed the JAM, and all of the
patients performed the PILE.
All functional tests were performed at admission and
at discharge (length of stay 31 ± 10 days).
Other data collected
At intake
General and sociodemographic variables (sex, age,
educational level, length of stay, duration of symptoms),
pain location (neck/back, upper limb, lower limb),
Abbreviated Injury Scale, the Brief Pain Inventory [26],
the Hospital Anxiety and Depression Scale [27]. The
educational level was split in “≤ 9 years” and “> 9 years”,
which corresponds to the compulsory school duration in
Switzerland (before the most recent reform, which set
this duration at 11 years for the start of the 2015/2016
academic year).
At discharge
The 7-level (GRC) from − 3: “much worse”, to + 3: “much
better”. All patients were specifically asked to answer the
GRC with respect to the injury they were hospitalized for.
Data collection and bias
Data at entry were collected before starting the thera-
peutic program. Records were collected electronically
with a digital pen. Functional tests were done under the
supervision of highly experienced physiotherapists, fa-
miliar with the tests through clear instructions and with
chronic pain through regular training: 73% of our phys-
iotherapists have received specific training in chronic
pain management; regular complementary training semi-
nars are organized at the clinic (at least twice a year) in
addition to weekly multidisciplinary meetings in each
hospitalization unit.
Estimation of the MCIDs
In addition to the ROC reference technique, we cal-
culated the SEM in cases where the ROC was not
conclusive. The Delphi process was also used to fulfill
the secondary objective.
Anchor-based method
Evidence supports the use of a 7 to 11-point numerical
scale [28] and the experience we have of our patients
supports the use of a 7-point scale rather than a 9 or a
11-point scale. The ROC technique was therefore ran
with a 7-level GRC as the subjective anchor. Patients in re-
habilitation services are generally treated intensively and
for several weeks (4–5 weeks in our clinic). For this reason,
we considered that a “slight” improvement (GRC= + 1)
was not clinically significant given the multidisciplinary re-
sources invested during the stay. In line with previous
works, we considered as a “significant improvement” GRC
scores ≥ + 2 [29, 30]. Correlations between GRC scores
and changes in functional scores were calculated in order
to check the “credibility” of the GRC as an anchor [19].
Also were calculated the correlations between GRC scores
and changes in the Brief Pain Inventory and the Hospital
Anxiety Depression Scale.
Distribution-based method
The SEM was calculated as the square root of the
mean square error term from a repeated-measure
ANOVA (intake and discharge), which has the advan-
tage of not being influenced by systematic error (in this
study, the effect of the therapeutic program between
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intake and discharge), compared to other methods that
rely on the Intraclass Correlation Coefficient [31].
Since an improvement was expected for every patient
between admission and discharge, we did not penal-
ized the SEM for systematic difference, which would
be due to the effect of the intervention, and not to a
lack of reliability.
Opinion-based method
The Delphi process was conducted with 19 experts (5
physicians, 9 physiotherapists and 5 occupational thera-
pists, having at least 5 years of experience in musculo-
skeletal rehabilitation). Three rounds were organized: (1)
gathering MCID values of each expert for the 6 scales;
(2) 2nd estimation, knowing the 1st round anonymous
results (mean-median-min-max for each scale); (3) 3rd
estimation, knowing the 2nd round anonymous results
and the arguments given by experts who gave the lowest
and highest values for each scale.
In the anchor-based and the distribution-based methods,
different estimations of the MCID were made separately
for upper-limb, lower-limb and neck/back lesions. As the
SEM is the score’s variation due to unreliability, MCIDs
smaller than the SEM were not considered valid. In the
opinion-based method, a single estimation was made for
each functional test. All statistical analyses were performed
using NCSS 9 [32].
Results
Participants
Between May 2014 and January 2016, one thousand and
forty-seven patients were admitted to the clinic for the
management of chronic pain after trauma to a limb or
spine, 838 patients were eligible for inclusion. Their
baseline characteristics, GRC and functional scores at
admission and discharge are reported in Tables 1 and 2.
The vast majority of our patients have had a bruise, a
sprain or a simple fracture of a limb or spine. A flow
chart with the number of patients assessed at intake and
at discharge is presented in Fig. 1. Depending on the le-
sion location and the functional scale, 57–92% patients
had both assessments.
Seven hundred and thirty five were male (88%), mean
age was 44 years ±11, median duration of painful symp-
toms was > 1 year (401 days). Mean length of stay in the
rehabilitation clinic was 31 days±10, 280 (34%) declared
a significant improvement during the stay, as defined by
a GRC between + 2 and + 3.
MCID - anchor-based method
For each functional test and each lesion location, one
ROC curve was drawn with the GRC as the condition
variable and the score progression (intake-discharge) as
the criterion variable. The optimal cutoff on the ROC
curve was determined as the value that gave the highest
Youden index (sensitivity+specificity-1), provided that
both sensitivity and specificity were simultaneously ≥60%.
Only MCIDs for the 6MWT, 1MSCT and JAM reached
this condition (Table 3). As an example of inconclusive es-
timation, the value of + 2.5 kg for the PILE gave 0.66/0.56
(good sensitivity/insufficient specificity) and + 5.0 kg gave
0.46/0.73 (insufficient sensitivity/good specificity), in pa-
tients with upper limb lesions. Therefore, we could only
Table 1 Baseline characteristics of patients
Characteristics N Values
Age 838 44 ± 11
Sex 838 735 (88%) male
Educational level 835
- ≤ 9 years 487 (58%)
- > 9 years 348 (42%)
Lesion location 838
- Neck/back 129 (15%)
- Upper limb 357 (43%)
- Lower limb 352 (42%)
AIS 818
- Minor 304 (37%)
- Moderate 514 (63%)
Duration of symptoms 837 Median [IQ]: 401 days [257–722]
Length of stay 838 31 ± 10
GRC 825
- Improved (GRC ≥ + 2) 280 (34%)
- Not improved (GRC < + 2) 545 (66%)
Values are presented as Mean(±Standard Deviation) or N(percentages), unless
stated otherwise. Age in years, Length of stay in days. AIS Abbreviated Injury
Scale, GRC Global Rating of Change. N number of patients
Table 2 Functional scores and questionnaires at admission and
at discharge
Functional scores N Admission Discharge p
6MWT 437 427 ± 127 492 ± 132 < 10− 6*
SRT 307 168 ± 88 204 ± 94 < 10− 6*
1MSCT 402 83 ± 37 100 ± 42 < 10− 6*
STS 400 19 ± 17 15 ± 13 < 10−6*
JAM 301 22 ± 15 26 ± 16 < 10−6*
PILE 627 16 ± 9 18 ± 9 < 10−6*
Questionnaires N Admission Discharge p
BPI 764 10 ± 4 9 ± 4 < 10−6*
HADS 803 18 ± 8 17 ± 9 0.004*
Values are presented as Mean(±Standard Deviation). N number of patients. 6-
Minute Walk Test (6MWT) in meters, Steep Ramp Test (SRT) in Watts, 1-Minute
Stair Climbing Test (1MSCT) in steps, Sit-To-Stand test (STS) in seconds, Jamar
dynamometer test (JAM) in Newtons, Progressive Isoinertial Lifting Evaluation
(PILE) in kg. BPI Brief Pain Inventory, HADS Hospital Anxiety and Depression
Scale. *Statistically significant
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state that a hypothetic MCID value for the PILE could
be estimated between + 2.5 and + 5.0 kg, depending on
whether we prioritize the sensitivity or the specificity
(+ 0.0 to + 2.5 kg in lower limb lesions, 2.5 kg to 5.0 kg
in neck/back lesions). In the same way, we found for
the STS -2.0 to − 3.3 s (lower limb) and − 4.0 to − 6.0 s
(neck/back), and for the SRT + 25 to + 55W (lower
limb) and + 25 to + 50W (neck/back). The correspond-
ing “area under the ROC curve”, which illustrated the
test’s performance as a binary classifier (“improve-
ment”/“no improvement”), ranged from 0.65 to 0.72.
GRC scores of patients with lower-limb and neck/back
Fig. 1 Flow chart of participants who performed functional tests both at intake and at discharge. AIS: Abbreviated Injury Scale. N: number of
patients. 6MWT: 6-Minute Walk Test, SRT: Steep Ramp Test, 1MSCT: 1-Minute Stair Climbing Test, STS: Sit-To-Stand test, JAM: Jamar dynamometer
test, PILE: Progressive Isoinertial Lifting Evaluation
Table 3 Results of the Anchor-based, Distribution and Opinion methods
Anchor-based method/Distribution method Opinion
Upper limb Lower limb Neck/Back
6MWT – + 75 / + 58 + 60 / + 55 + 83
SRT – NR (+ 25 to + 55) / +39 NR (+ 25 to + 50) / + 44 +61
1MSCT – + 18 / + 16 + 15 / + 18 + 25
STS – NR (−2.0 to −3.3) / -5 NR (−4.0 to −6.0) / -7 −6
JAM + 5 / + 6 – – + 9
PILE NR (+ 2.5 to + 5.0) / + 4 NR (0 to + 2.5) / + 4 NR (+ 2.5 to + 5.0) / + 4 + 7
NR Not Relevant, only a range of values is given because no values are associated with both sensitivity and specificity ≥60% (the range boundaries correspond to
the thresholds with either 60% sensitivity or 60% specificity). 6-Minute Walk Test (6MWT) in meters, Steep Ramp Test (SRT) in Watts, 1-Minute Stair Climbing Test
(1MSCT) in steps, Sit-To-Stand test (STS) in seconds, Jamar dynamometer test (JAM) in Newtons, Progressive Isoinertial Lifting Evaluation (PILE) in kg
Benaim et al. BMC Musculoskeletal Disorders           (2019) 20:16 Page 5 of 9
lesions correlated with changes in the 6MWT and
1MSCT scores (Table 4); GRC scores of patients with
upper-limb lesions correlated with changes in the JAM
and PILE scores. All of these correlations reached the
recommended value of 0.3–0.4 [23, 24]. GRC scores
also correlated significantly with changes in the Brief
Pain Inventory (r = − 0.40, p < 10− 6) and the Hospital
Anxiety and Depression Scale (r = − 0.22, p < 10− 6). It
was not influenced by age or sex.
MCID - distribution-based and opinion-based methods
SEM values for each functional score according to lesion
location are also reported in Table 3, as are the Round 3
Delphi results. For all tests except the SRT, the estima-
tions made by physiotherapists and occupational thera-
pists were 25–83% higher than those made by physicians
(96 m/58w/27 steps/11 kg/8 kg, vs. 60 m/69w/21 steps/6
kg/6 kg), respectively.
Discussion
Using the Anchor-based method, the MCIDs of the
6MWT and 1MSCT were estimated at + 75m / + 18 steps
(lower-limb lesions) and + 60m / + 15 steps (neck-back le-
sions) and the MCID of the JAM was estimated at + 5 kg
(upper-limb lesions). For the SRT, STS and PILE, only
distribution-based and opinion-based estimations were
relevant (sensitivity and specificity criterion not met for the
anchor method): + 39w to + 61w, − 5 s to − 7 s and + 4 kg
to + 7 kg, depending on the method and the lesion loca-
tion. The above values may be used as a basis for interpret-
ing clinical changes in a patient or in a group of patients
participating in a therapeutic trial, and in determining the
minimal sample size in a new trial.
Distribution-based and Anchor-based estimations were
close to each other in many cases. This is consistent
with previous studies, in which MCIDs based on pa-
tients’ global rating as the anchor were close to the value
of one SEM [33, 34]. On the other hand, most MCIDs in
the opinion-based method were higher than those in the
other methods. This was mainly due to the more
optimistic judgment of therapists as the functional im-
provement they expected was greater than that expected
by the physicians and by the patients themselves. An-
other hypothesis is that our physicians had an overall
view of the patients across the different therapies and
over time, including before and after the rehabilitation
program, whereas our therapists focused on their own
domain and were less familiar with the long-term
follow-up. Physicians may also have been more aware
than our therapists about previously published values of
MCID, and could have been influenced by the literature.
For example, MCIDs for the 6MWT did not exceed 25
m in a previous study on cardiac rehabilitation, in which
one of the authors of the present article took part [11].
We can speculate that the other physicians on the opin-
ion team were not inclined to set an MCID as high as
96 m, the improvement set by the therapists.
Some authors have argued that the anchor-based ap-
proach is the best choice because it is the only method
that addresses the patient’s perspective. In a recent review
of the literature on MCID estimations for the 6MWT,
Bohannon et al. [20] only took into consideration articles
using this particular approach and excluded articles
reporting procedures other than the ROC analysis, as
recommended by Terwee et al. [22]. For Turner et al.,
distribution-based indicators should only be used “as tem-
porary substitutes pending availability of empirically
established anchor-based indicators” [21]. On the other
hand, the MCID should be at least equal to the SEM,
which measures the variation due to unreliability [23].
For all of the above reasons, the highest MCIDs for
the Anchor-based and Distribution-based estimations
should be considered acceptable: + 75 m and + 60 m
for the 6MWT (lower-limb and neck/back lesions, re-
spectively), + 18 steps and + 18 steps for the 1MSCT
(lower-limb and neck/back lesions, respectively) and +
6 kg for the JAM.
Our results showed that the lesion location also
affected MCIDs. This result was not surprising at all
because walking performance is more severely impaired
in patients with lower-limb lesions than in those with
neck/back lesions, and the former obviously expect a
greater improvement in function directly related to their
lesion. As anticipated, MCID estimations differed from
previously published values in different groups of pa-
tients. For example, MCIDs of the 6MWT have been
estimated at 20 m for patients with Duchenne muscular
dystrophy [13] and at 25 m in patients with coronary ar-
tery disease [11], which is far less than the present value
in the lower-limb group. However, it is not surprising to
note that the expected improvement in walking per-
formance is lower in boys with a Duchenne muscular
dystrophy than in chronic musculoskeletal pain patients.
The low MCID value in coronary artery patients could
Table 4 Correlation coefficients between the GRC (− 3 to + 3)
and changes in scores (Δ = follow up score – baseline score)
Changes in Scores Upper limb Lower limb Neck/Back
Δ 6MWT – 0.351a 0.372a
Δ SRT – 0.220a 0.184
Δ 1MSCT – 0.424a 0.331a
Δ STS – 0.067 −0.046
Δ JAM 0.338a – –
Δ PILE 0.312a 0.241a 0.171
6MWT: 6-Minute Walk Test, SRT Steep Ramp Test, 1MSCT 1-Minute Stair
Climbing Test, STS Sit-To-Stand test, JAM Jamar dynamometer test, PILE
Progressive Isoinertial Lifting Evaluation. aStatistically significant
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be explained by pathological or psychological factors.
The choice of a different anchor could also partly ex-
plain this difference (same limit at 2, but 9-level vs.
7-level GRC in the present study). Different MCID
values for the 6MWT in different settings are available
in Bohannon et al. [20]. The MCID of the PILE was esti-
mated at + 2.5 kg in chronic back pain patients complet-
ing a functional restoration program [14], which is a bit
less than our 4 kg. This difference could be explained by
the great proportion of men in our cohort (88% vs. 59%
in Gatchel [14]). The MCID of STS was previously esti-
mated at 1.7 s in patients with chronic obstructive pul-
monary disease and at 2.3 s in vestibular rehabilitation
[35, 36], which is far less than in our patients. In the first
case, patients’ performances at baseline were as good as our
patients’ performances at discharge. Therefore, the poten-
tial for improvement was lower. In the second case, the
presence of neurological balance disorders may explain a
relatively small MCID value. It was estimated for the JAM
at 5.0–6.2 kg in stroke and 6.5 kg in distal radius fracture,
which is close to our estimations, and to 0.84 kg in a popu-
lation of 70 to 90 year old females with thumb carpometa-
carpal osteoarthritis, which is much less than in our
population of mostly male blue-collar workers [37–39].
Parameters other than the disease may influence MCID
estimations. For instance, the MCID for the JAM in stroke
patients was lower if the motor deficiency affected the
dominant hand (5 kg) rather than the non-dominant hand
(6.2 kg) [37], and the MCID for the 6MWT varies over the
course of the disease, as is the case in subacute or chronic
stroke (61 vs. 34.4m) [40].
It is therefore crucial to estimate MCIDs in homoge-
neous groups of patients, and our very large population
made it possible to produce separate MCID estimations
for chronic musculoskeletal pain patients with lower-limb,
upper-limb and neck/back lesions.
This is the first study to attempt to estimate the
MCID of six functional tests simultaneously and separ-
ately in patients with upper-limb, lower-limb and neck/
back lesions. We used three different approaches, in-
cluding the anchor-based approach with ROC analysis,
which is considered the reference method by some au-
thors [19–22]. Although we believe that selecting an-
chors that are specific to each performance test could
have led to slightly different results, our global anchor
GRC was validated a posteriori for the 6MWT, 1MSCT
and JAM, as it was found to correlate strongly enough
with changes in these scores (r > 0.3). GRC scores also
correlated strongly with changes in mood and pain
scales, suggesting that pain and psychological improve-
ments also contributed to patients’ satisfaction. Con-
versely, GRC scores correlated less strongly with scores
improvement of SRT, STS and PILE, but we can assume
that the MCIDs might have been estimated for these
three scales with anchors specifically related to strength
or endurance.
Study limitations
The main limitation of this study was a potential selec-
tion bias because all of our patients were of working age
(18–65), mostly men and presented with lesion in only
one area (neck/back, upper limb or lower limb). It is
more than likely that MCID estimations would have
been slightly lower in an older population or might have
differed in a predominantly female population. Another
limitation is that we cannot guaranty that all patients
specifically answered the GRC with respect to the lesion
injury they were hospitalized for. For example, a patient
presenting with a chronic low back pain and comes to
rehabilitation for a leg injury could be influenced by the
back pain when completing the GRC. If we had not in-
cluded this kind of patients, we might have estimated
more MCID values with the ROC technique, but we
would have deviated from real-life conditions.
Finally, we are aware that our way of evaluating the
SEM is not ideal, because it is based on repeated measures
with an intervention in between, but no data were avail-
able with repeated evaluations within a short time period.
Moreover, it was not possible to implement such repeated
evaluations in the therapeutic program of the patients,
which is already very dense. However, our estimation is
not penalized by a systematic bias (which is here due to
the effect of the intervention, and not to a lack of reliabil-
ity) and is in line with Rousson’s recommendations [41].
Tangent to this debate, and importantly, one should
remember that the MCID is of limited value in the man-
agement of individuals taking part in multidisciplinary
rehabilitation programs. By way of illustration, let us say
that + 5 kg is a good estimation of the MCID for the
JAM in patients with painful upper limb lesions. This
only means that most patients who are satisfied with
their clinical outcome after a multidisciplinary rehabilita-
tion program have improved their grip strength by at
least + 5 kg in this test. Now let us imagine that the main
focus of a new rehabilitation program is grip strength to
the detriment of other dimensions, like hand dexterity,
bimanual activities, pain management, psychological
support, etc. A high percentage of patients who reached
this grip-strength MCID could be “globally unsatisfied”
as their objectives in the other aspects were not met.
This leads us to the opinion that the present estimations
of MCIDs are not tailored for “all chronic musculoskel-
etal pain patients”, but for “chronic musculoskeletal pain
patients participating in a vocational oriented multidis-
ciplinary rehabilitation program”, where grip strength,
walking speed or climbing stairs are only three aspects
of many. In other words, these values should not be used
to set goals at an individual level, unless the patient
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explicitly expresses a wish to increase grip strength, or
walk or climb stairs faster.
Conclusion
MCIDs were estimated at + 75m and + 60m for the
6MWT (lower-limb and neck/back lesions, respectively), +
18 steps for the 1MSCT (lower-limb and neck/back lesions)
and + 6 kg for the JAM (upper limb lesions). Distribution
and opinion-based methods provided rough estima-
tions of MCIDs for the SRT (+ 39w to + 61w), the STS
(− 5 s to -7 s) and the PILE (+ 4 kg to + 7 kg). The use
of specific anchors might eventually give better estima-
tions for these three scales. Future research is needed to
estimate MCIDs for functional scales in older chronic
musculoskeletal pain patients.
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